Medinotec Inc. financial data

Symbol
MDNC on OTC
Location
Johannesburg
Fiscal year end
28 February
Latest financial report
10-Q - Q3 2025 - 08 Oct 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 368% % -23%
Debt-to-equity 59% % -43%
Return On Equity 55% %
Return On Assets 35% %
Operating Margin 29% % 74%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 11,755,548 shares 0.19%
Common Stock, Shares, Outstanding 11,755,548 shares 0.19%
Common Stock, Value, Issued $11,756 USD 0.19%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $11,428,040 USD 56%
Cost of Revenue $4,546,393 USD -105%
Research and Development Expense $60,823 USD -35%
Selling and Marketing Expense $538,002 USD 2905%
General and Administrative Expense $1,311,825 USD 16%
Operating Income (Loss) $3,292,606 USD 172%
Nonoperating Income (Expense) $88,046 USD 89%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $3,204,560 USD 750%
Income Tax Expense (Benefit) $759,355 USD -1148%
Net Income (Loss) Attributable to Parent $2,247,870 USD 22%
Earnings Per Share, Basic 0 USD/shares 50%
Earnings Per Share, Diluted 0.03 USD/shares 50%

Balance Sheet

Label TTM Value / Value Unit Change %
Accounts Receivable, after Allowance for Credit Loss, Current $2,575,271 USD 234%
Other Assets, Current $161,238 USD 60%
Assets, Current $5,978,678 USD 22%
Property, Plant and Equipment, Net $333,296 USD 1.9%
Operating Lease, Right-of-Use Asset $25,542 USD -52%
Assets $6,371,882 USD 20%
Employee-related Liabilities, Current $31,523 USD 18%
Liabilities, Current $1,534,089 USD -2%
Operating Lease, Liability, Noncurrent $5,355 USD -84%
Liabilities $1,534,532 USD -45%
Accumulated Other Comprehensive Income (Loss), Net of Tax $41,770 USD -54%
Stockholders' Equity Attributable to Parent $4,837,350 USD 91%
Liabilities and Equity $6,371,882 USD 20%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $759,238 USD -408%
Net Cash Provided by (Used in) Financing Activities $37,900 USD 93%
Common Stock, Shares, Issued 11,755,548 shares 0.19%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $818,809 USD -183%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2,248,095 USD -18%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $2,198,635 USD 29%
Property, Plant and Equipment, Gross $1,642,762 USD -2.7%
Operating Lease, Liability, Current $28,716 USD 3.5%
Deferred Income Tax Expense (Benefit) $7,452 USD -62%
Current Income Tax Expense (Benefit) $1,204,702 USD -275%
Preferred Stock, Shares Authorized 20,000,000 shares 0%
Additional Paid in Capital $3,405,359 USD 3.3%
Operating Leases, Future Minimum Payments, Due in Two Years $13,832 USD -56%
Depreciation, Depletion and Amortization $7,506 USD -68%
Operating Leases, Future Minimum Payments Due $28,716 USD -49%
Interest Expense $209,324 USD -486%